Industry Experts

Ishaan Chetty is a Summa Cum Laude graduate of Whittier College, where he earned a bachelor's degree in Biochemistry with a minor in Business Administration. He is the Co-Founder and Vice President of Grann Pharmaceuticals, a company focused on developing mRNA-based solid lipid nanoparticle therapies targeting a range of diseases including Alzheimer’s, Dementia, NASH, Leukemia, and several rare genetic disorders such as Angelman Syndrome, KCNT1-related Epilepsy, and Rett Syndrome.

Ishaan specializes in the in-vitro isolation and synthesis of mRNA and its formulation into solid lipid nanoparticles, contributing to Grann’s mission to advance next-generation RNA therapeutics for some of the world’s most challenging diseases.